|
1
|
Conti-Fine BM, Milani M and Kaminski HJ:
Myasthenia gravis: Past, present and future. J Clin Invest.
116:2843–2854. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cavalcante P, Barberis M, Cannone M, Baggi
F, Antozzi C, Maggi L, Cornelio F, Barbi M, Dido P, Berrih-Aknin S,
et al: Detection of poliovirus-infected macrophages in thymus of
patients with myasthenia gravis. Neurology. 74:1118–1126. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xie Y, Li HF, Jiang B, Li Y, Kaminski HJ
and Kusner LL: Elevated plasma interleukin-17A in a subgroup of
Myasthenia Gravis patients. Cytokine. 78:44–46. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee JS, Joo IS and Seok JI: Widely varying
TNF-alpha levels in patients with myasthenia gravis. Neurol Sci.
30:259–262. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li Q, Liu P, Xuan X, Zhang J, Zhang Y, Zhu
Z, Gao F, Zhang Q and Du Y: CCR9 AND CCR7 are overexpressed in CD4
CD8 thymocytes of myasthenia gravis patients. Muscle Nerve.
55:84–90. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang L, Wang J, Sun X, Cao Y, Ning S,
Zhang H, Chen L, Li R, Tian Q, Wang L, et al: Identifying a
polymorphic ‘switch’ that influences miRNAs' regulation of a
myasthenia gravis risk pathway. PLoS One. 9:e1048272014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cao Y, Lu X, Wang J, Zhang H, Liu Z, Xu S,
Wang T, Ning S, Xiao B and Wang L: Construction of an
miRNA-regulated drug-pathway network reveals drug repurposing
candidates for myasthenia gravis. Int J Mol Med. 39:268–278. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xin Y, Cai H, Lu T, Zhang Y, Yang Y and
Cui Y: miR-20b Inhibits T cell proliferation and activation via
NFAT signaling pathway in thymoma-associated myasthenia gravis.
Biomed Res Int 2016. 95957182016.
|
|
9
|
Li J, Qiu D, Chen Z, Du W, Liu J and Mo X:
Altered expression of miR-125a-5p in thymoma-associated myasthenia
gravis and its down-regulation of foxp3 expression in Jurkat cells.
Immunol Lett. 172:47–55. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu XF, Wang RQ, Hu B, Luo MC, Zeng QM,
Zhou H, Huang K, Dong XH, Luo YB, Luo ZH and Yang H: MiR-15a
contributes abnormal immune response in myasthenia gravis by
targeting CXCL10. Clin Immunol. 164:106–113. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Leonardo TR, Schultheisz HL, Loring JF and
Laurent LC: The functions of microRNAs in pluripotency and
reprogramming. Nat Cell Biol. 14:1114–1121. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kästle M, Bartel S, Geillinger-Kästle K,
Irmler M, Beckers J, Ryffel B, Eickelberg O and Krauss-Etschmann S:
microRNA cluster 106a~363 is involved in T helper 17 cell
differentiation. Immunology. 152:402–413. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kuppers DA, Schmitt TM, Hwang HC, Samraj
L, Clurman BE and Fero ML: The miR-106a~363Xpcl1 miRNA
cluster induces murine T cell lymphoma despite transcriptional
activation of the p27Kip1 cell cycle inhibitor.
Oncotarget. 8:50680–50691. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kurkewich JL, Hansen J, Klopfenstein N,
Zhang H, Wood C, Boucher A, Hickman J, Muench DE, Grimes HL and
Dahl R: The miR-23a~27a~24-2 microRNA cluster buffers transcription
and signaling pathways during hematopoiesis. PLoS Genet.
13:e10068872017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pinero J, Queralt-Rosinach N, Bravo A,
Deu-Pons J, Bauer-Mehren A, Baron M, Sanz F and Furlong LI:
DisGeNET: A discovery platform for the dynamical exploration of
human diseases and their genes. Database (Oxford) 2015. bav0282015.
View Article : Google Scholar
|
|
16
|
Amberger JS, Bocchini CA, Schiettecatte F,
Scott AF and Hamosh A: OMIM.org: Online mendelian inheritance in
man (OMIM®), an online catalog of human genes and
genetic disorders. Nucleic Acids Res. 43:(Database Issue).
D789–D798. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kozomara A and Griffiths-Jones S: miRBase:
Integrating microRNA annotation and deep-sequencing data. Nucleic
Acids Res. 39:(Database Issue). D152–D157. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Brown GR, Hem V, Katz KS, Ovetsky M,
Wallin C, Ermolaeva O, Tolstoy I, Tatusova T, Pruitt KD, Maglott DR
and Murphy TD: Gene: A gene-centered information resource at NCBI.
Nucleic Acids Res. 43:(Database Issue). D36–D42. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang J, Cao Y, Zhang H, Wang T, Tian Q, Lu
X, Lu X, Kong X, Liu Z, Wang N, et al: NSDNA: A manually curated
database of experimentally supported ncRNAs associated with nervous
system diseases. Nucleic Acids Res. 45:D902–D907. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hsu SD, Tseng YT, Shrestha S, Lin YL,
Khaleel A, Chou CH, Chu CF, Huang HY, Lin CM, Ho SY, et al:
miRTarBase update 2014: An information resource for experimentally
validated miRNA-target interactions. Nucleic Acids Res.
42:(Database Issue). D78–D85. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dennis G Jr, Sherman BT, Hosack DA, Yang
J, Gao W, Lane HC and Lempicki RA: DAVID: Database for annotation,
visualization and integrated discovery. Genome Biol. 4:P32003.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The gene
ontology consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Smith-Bouvier DL, Divekar AA, Sasidhar M,
Du S, Tiwari-Woodruff SK, King JK, Arnold AP, Singh RR and Voskuhl
RR: A role for sex chromosome complement in the female bias in
autoimmune disease. J Exp Med. 205:1099–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chitnis T and Khoury SJ: Sex influences in
autoimmune disease. Clin Immunol. 149:1692013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhu ML, Bakhru P, Conley B, Nelson JS,
Free M, Martin A, Starmer J, Wilson EM and Su MA: Sex bias in CNS
autoimmune disease mediated by androgen control of autoimmune
regulator. Nat Commun. 7:113502016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cao M, Seike M, Soeno C, Mizutani H,
Kitamura K, Minegishi Y, Noro R, Yoshimura A, Cai L and Gemma A:
MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition
by targeting E-cadherin in lung cancer cells. Int J Oncol.
41:869–875. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kitamura K, Seike M, Okano T, Matsuda K,
Miyanaga A, Mizutani H, Noro R, Minegishi Y, Kubota K and Gemma A:
MiR-134/487b/655 cluster regulates TGF-β-induced
epithelial-mesenchymal transition and drug resistance to gefitinib
by targeting MAGI2 in lung adenocarcinoma cells. Mol Cancer Ther.
13:444–453. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Suffert G, Malterer G, Hausser J,
Viiliainen J, Fender A, Contrant M, Ivacevic T, Benes V, Gros F,
Voinnet O, et al: Kaposi's sarcoma herpesvirus microRNAs target
caspase 3 and regulate apoptosis. PLoS Pathog. 7:e10024052011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Naidu S, Shi L, Magee P, Middleton JD,
Lagana A, Sahoo S, Leong HS, Galvin M, Frese K, Dive C, et al:
PDGFR-modulated miR-23b cluster and miR-125a-5p suppress lung
tumorigenesis by targeting multiple components of KRAS and NF-kB
pathways. Sci Rep. 7:154412017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li SG, Shi QW, Yuan LY, Qin LP, Wang Y,
Miao YQ, Chen Z, Ling CQ and Qin WX: C-Myc-dependent repression of
two oncogenic miRNA clusters contributes to triptolide-induced cell
death in hepatocellular carcinoma cells. J Exp Clin Cancer Res.
37:512018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Llobet-Navas D, Rodriguez-Barrueco R,
Castro V, Ugalde AP, Sumazin P, Jacob-Sendler D, Demircan B,
Castillo-Martin M, Putcha P, Marshall N, et al: The miR-424
(322)/503 cluster orchestrates remodeling of the epithelium in the
involuting mammary gland. Genes Dev. 28:765–782. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cavalcante P, Galbardi B, Franzi S,
Marcuzzo S, Barzago C, Bonanno S, Camera G, Maggi L, Kapetis D,
Andreetta F, et al: Increased expression of Toll-like receptors 7
and 9 in myasthenia gravis thymus characterized by active
Epstein-Barr virus infection. Immunobiology. 221:516–527. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Grauer O, Wolff D, Bertz H, Greinix H,
Kuhl JS, Lawitschka A, Lee SJ, Pavletic SZ, Holler E and Kleiter I:
Neurological manifestations of chronic graft-versus-host disease
after allogeneic haematopoietic stem cell transplantation: Report
from the Consensus Conference on Clinical Practice in chronic
graft-versus-host disease. Brain. 133:2852–2865. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Unal S, Sag E, Kuskonmaz B, Kesici S,
Bayrakci B, Ayvaz DC, Tezcan I, Yalnizoglu D and Uckan D:
Successful treatment of severe myasthenia gravis developed after
allogeneic hematopoietic stem cell transplantation with plasma
exchange and rituximab. Pediatr Blood Cancer. 61:928–930. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Heidarzadeh Z, Mousavi SA, Ostovan VR and
Nafissi S: Muscle-specific kinase antibody associated myasthenia
gravis after bone marrow transplantation. Neuromuscul Disord.
24:148–150. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cioffi M, Trabulo SM, Vallespinos M, Raj
D, Kheir TB, Lin ML, Begum J, Baker AM, Amgheib A, Saif J, et al:
The miR-25-93-106b cluster regulates tumor metastasis and immune
evasion via modulation of CXCL12 and PD-L1. Oncotarget.
8:21609–21625. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Punga T, Bartoccioni E, Lewandowska M,
Damato V, Evoli A and Punga AR: Disease specific enrichment of
circulating let-7 family microRNA in MuSK+ myasthenia gravis. J
Neuroimmunol. 292:21–26. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wu Y, Heinrichs J, Bastian D, Fu J, Nguyen
H, Schutt S, Liu Y, Jin J, Liu C, Li QJ, et al: MicroRNA-17-92
controls T-cell responses in graft-versus-host disease and leukemia
relapse in mice. Blood. 126:1314–1323. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wu D, Bi X, Qu L, Han L, Yin C, Deng J,
Dong Z, Mi QS and Zhou L: miRNA miR-17-92 cluster is differentially
regulated in the imiqumod-treated skin but is not required for
imiqumod-induced psoriasis-like dermatitis in mice. Exp Dermatol.
26:82–84. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
de Kouchkovsky D, Esensten JH, Rosenthal
WL, Morar MM, Bluestone JA and Jeker LT: microRNA-17-92 regulates
IL-10 production by regulatory T cells and control of experimental
autoimmune encephalomyelitis. J Immunol. 191:1594–1605. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Geng XR, Qiu SQ, Yang LT, Liu ZQ, Yang G,
Liu JQ, Zeng L, Li XX, Mo LH, Liu ZG and Yang PC: Allergen-specific
immune response suppresses interleukin 10 expression in B cells via
increasing micro-RNA-17-92 cluster. Cell Biochem Funct. 34:449–454.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chandran PA, Keller A, Weinmann L, Seida
AA, Braun M, Andreev K, Fischer B, Horn E, Schwinn S, Junker M, et
al: The TGF-β-inducible miR-23a cluster attenuates IFN-γ levels and
antigen-specific cytotoxicity in human CD8+ T cells. J
Leukoc Biol. 96:633–645. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Cho S, Wu CJ, Yasuda T, Cruz LO, Khan AA,
Lin LL, Nguyen DT, Miller M, Lee HM, Kuo ML, et al: miR-23
approximately 27 approximately 24 clusters control effector T cell
differentiation and function. J Exp Med. 213:235–249. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kurkewich JL, Bikorimana E, Nguyen T,
Klopfenstein N, Zhang H, Hallas WM, Stayback G, McDowell MA and
Dahl R: The mirn23a microRNA cluster antagonizes B cell
development. J Leukoc Biol. 100:665–677. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ventura A, Young AG, Winslow MM, Lintault
L, Meissner A, Erkeland SJ, Newman J, Bronson RT, Crowley D, Stone
JR, et al: Targeted deletion reveals essential and overlapping
functions of the miR-17 through 92 family of miRNA clusters. Cell.
132:875–886. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Jiang S, Li C, Olive V, Lykken E, Feng F,
Sevilla J, Wan Y, He L and Li QJ: Molecular dissection of the
miR-17-92 cluster's critical dual roles in promoting Th1 responses
and preventing inducible Treg differentiation. Blood.
118:5487–5497. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Khan AA, Penny LA, Yuzefpolskiy Y, Sarkar
S and Kalia V: MicroRNA-17~92 regulates effector and memory CD8
T-cell fates by modulating proliferation in response to infections.
Blood. 121:4473–4483. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Olive V, Li Q and He L: mir-17-92: A
polycistronic oncomir with pleiotropic functions. Immunol Rev.
253:158–166. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wang B, Zhang C, Zhang A, Cai H, Price SR
and Wang XH: MicroRNA-23a and MicroRNA-27a mimic exercise by
ameliorating CKD-induced muscle atrophy. J Am Soc Nephrol.
28:2631–2640. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Su R, Dong L, Zou D, Zhao H, Ren Y, Li F,
Yi P, Li L, Zhu Y, Ma Y, et al: microRNA-23a, −27a and −24
synergistically regulate JAK1/Stat3 cascade and serve as novel
therapeutic targets in human acute erythroid leukemia. Oncogene.
35:6001–6014. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Li X, Liu X, Xu W, Zhou P, Gao P, Jiang S,
Lobie PE and Zhu T: c-MYC-regulated miR-23a/24-2/27a cluster
promotes mammary carcinoma cell invasion and hepatic metastasis by
targeting Sprouty2. J Biol Chem. 288:18121–18133. 2013. View Article : Google Scholar : PubMed/NCBI
|
